Réseau Entre la Ville et l'Hôpital pour l'Orthogénie

Bibliographie en anglais

l'IVG dans le monde

Intitulé Description Date
Results-4year-study-medical-abortions-France.pdf

Publication d'une étude réalisée par le réseau
Results of a 4-year study on 15,447 medical abortions provided by privately practicing general practitioners and gynecologists in France


2012
cout_mif_miso_
versus_miso.pdf
Differences costs using mifepristone and misoprostol or misoprostol alone, CREININ, Contraception, 2005 2005
guengant.pdf Mifepristone-Misoprostol medical abortion , GUENGANT, Contraception, 1999 1999
hausknecht.pdf Mifepristone-Misoprostol medical abortion , HAUSKNECHT, Contraception, 2003 2003
medical_abortion_
in-tunisia.pdf
Medical abortion experiences of married and unmarried women in Tunisia , Contraception, 2004 2004
miso_et_chute_
mortalite_ivg.pdf
Misoprostol and declining abortion related morbidity in the dominican republic , BJOG, 2005 2005
population_council.pdf The population council, Contraception, 1998 1998
tunisia_2004.pdf Expanding medical abortion in Tunisia : women’s experiences from a multi-site expansion study, Contraception, 2004 2004
turquie_2004.pdf Results and lessons learned from a small medical abortion clinical study in Turkey , Contraception, 2004 2004
usa.pdf Could American women use mifepristone-misoprostol pills safely with less medical supervision ? Contraception, 2002 2002
vietnam_2004.pdf Is home-based administration of prostaglandin safe and feasible for medical abortion ? Results from a multisite study in Vietnam , BJOG 2004 2004

Généralités

Intitulé Description Date
current_care_creinin.pdf Current Medical Abortion Care
ectopic_and_medical_
abortion.pdf
Ectopic Pregnancy and Medical Abortion
harper.pdf Could American women use mifepristone-misoprostol pills safely with less medical supervision?
hedley.pdf less medical supervision?
home_abortion_uk.pdf The acceptability of home medical abortion to women in UK settings
home_use_fiala.pdf Acceptability of home-use of misoprostol in medical abortion
infection.pdf Infection after medical abortion: a review of the literature
medical_abortion.pdf Medical abortion and the risk of subsequant adverse pregancy outcomes 16/08/2007
medical_methods_for_
first_trimester_abortion.pdf
Medical methods for first trimester abortion
medical_versus_
chirurgical.pdf
Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study
meta_kahn.pdf Meta-Analysis of Medical Abortion Efficacy
phelps.pdf Mifepristone abortion in minors
Results-4year-study-medical-abortions-France.pdf Results of a 4-year study on 15,447 medical abortions provided by privately practicing general practitioners and gynecologists in France 14/06/2012
safety_of_mifepristone
_abortions.pdf
Safety of mifepristone abortions in clinical use
schaff.pdf Mifepristone and misoprostol for early abortion when no gestational sac is present

Numéro spécial 2006

Intitulé Description Date
contrindications.pdf Mifepristone and prostaglandin for termination of pregnancy: contraindications for use, reasons and rationale
 diminuer_intervalle.pdf Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion
 dose_miso.pdf Mifepristone dose in the regimen with misoprostol for medical abortion
 effets_sec_complications.pdf Mifepristone and misoprostol sequential regimen side effects, complications and safety
 fresquent_asked_question.pdf Frequently asked questions about medical abortion
 mifepristone_200_600.pdf A systematic review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation
 pharmaco.pdf The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion
 review_fiala.pdf Review of medical abortion using mifepristone in combination with a prostaglandin analogue
 traitement_douleur.pdf Treatment of pain during medical abortion
 women_perceptions.pdf Women’s perceptions on medical abortion

Pharmacologie

Intitulé Description Date
concentration_sublinguale
_buccale.pdf
Comparison of misoprostol plasma concentrations following buccal and sublingual administration
critical_issues_in
_reproductive_healt.pdf
Critical Issues in Reproductive Health : Misoprostol and Teratogenicity: Reviewing the Evidence
oral_rectal_vaginal_
pharmacokinetics
_misoprostol.pdf
Oral, Rectal, and Vaginal Pharmacokinetics of Misoprostol
pharmaco_mifegyne.pdf Pharmacological properties of mifepristone: toxicology and safety in animal and human studies

Surveillance avortement

Intitulé Description Date
accounting_for_time.pdf Accounting for time: Insights from a life-table analysis of the efficacy of medical abortion
curettage_after
_mifepristone.pdf
Curettage After Mifepristone-Induced Abortion: Frequency, Timing, and Indications
harwood.pdf Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion
incomplete_abortion
_600.pdf
A randomized Trial of Misoprostol  Compared with manual vacuum aspiration for incomplete abortion
infection_medical
_abortion.pdf
A Fatal Case of Clostridium sordellii Septic Shock Syndrome Associated With Medical Abortion
peritonite_post_ru.pdf Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion
prediction_clinique.pdf Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion
westhoff.pdf Quality of life following early medical or surgical abortion

Variations du protocole

Intitulé Description Date
6h_versus_24h.pdf A Randomized Comparison of Misoprostol 6 to 8 Hours Versus 24 Hours After Mifepristone for Abortion
creinin100mg.pdf Mifepristone 100 mg in Abortion Regimens
Effectiveness_medical abortion_mifepristone_buccal.pdf Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days
eric_a_shaff_24h.pdf Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion
fox.pdf Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days’ gestation
hamoda.pdf A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation
ivg_med_13_sa_miso
_sublingual.pdf
A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation
miso_2eme_dose.pdf A systematic review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation
miso_sublingual_2009.pdf Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol
miso_versus_mifemiso.pdf A Prospective Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Mifepristone and Vaginal Misoprostol to Vaginal Misoprostol Alone for Elective Termination of Early Pregnancy
sameday.pdf A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days
sameday49j.pdf A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation
schaff.pdf Low-Dose Mifepristone 200 mg and Vaginal Misoprostol for Abortion
shanon.pdf Multicenter Trial of a Simplified Mifepristone Medical Abortion Regimen
tang.pdf Pilot study on the use of sublingual misoprostol for medical abortion
Unexpected_heaping_reported_
gestational_age.pdf
Unexpected heaping in reported gestational age for women undergoing medical abortion

Douleurs

Intitulé Description Date
carolyn_westhoff.pdf Predictors of Analgesia Use During Supervised Medical Abortion
de_nonno.pdf Timing of pain and bleeding after mifepristone-induced abortion
westhoffa.pdf Analgesia during at-home use of misoprostol as part of a medical abortion regimen

Mise à jour : 21/12/09

Mentions légales

l

® REVHO 2006

l

Ecrivez-nous